IPD Analytics publishes a semiannual Drug Pipeline and Trend Impact Report, which identifies new brands, generics, and biosimilars across over 40 therapeutic areas. Our team of pharmacists, PhD scientists, and intellectual property attorneys are consistently scanning and analyzing the landscape to provide insight into trending classes that are impacting drug spend.
From our recently published Drug Pipeline Report for
1H 2020, we share five key drug pipeline areas to watch in the first half of 2020—as well as one that might surprise you.
TOP 5 DRUG PIPELINE AREAS TO WATCH
IN EARLY 2020
